1Sibal L, Jovanovic A, Agarwal S C, et al. Phaeochromocytomas presenting as acute crises at'ter beta blockade therapy. Clinical Endocrinology, 2006, 65: 186-190.
2O'Connor, D T. The adrenal medulla, catecholamines, and phaeoehromocytoma// Cecil R L, Goldman L, Ausiello D A. Cecil's Textbook of Medicine. Philadelphia, P A; Saunders, 2003: 1419-1424.
3Armstrong R, Sridhar M, Greenhalgh K L, et al. Phaeochromocytoma in children. Arch Dis Child. 2008, 93: 899-904.
4OpochnerG, Schiavi F, Iacobone, M, et al. Familial nonsyndromic phaeochromocytoma. Ann NY Acad Sei, 2006, 1073: 149-155.
5Bausch B, Borozdin W, Mautner V F, et al. Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofihromatosis type 1. J Clin Endocrinol Metab, 2007, 92: 2784-2792.
6Birke B, Ann-Cathrin K, Martin F, et al. Comprehensive mutation scanning of NF1 in apparently sporadic cases of pheochromocytoma. J Clin Endocrinol Metab, 2006, 91: 3478-3481.
7Gimenez-Roqueplo A P, Burnichon N, Amar L, et al. Recent advances in the genetics of phaeochromocytoma and functional paraganglioma. Clin Exp Pharmacol Physiol, 2008, 35:376-379.
8Young W F, Abboud A L. Paraganglioma-all in the family. J Clin Endocrinol Metab, 2006, 91: 790- 792.
9Machens A, Brauckhoff M, Holzhausen H J, et al. Codon specific development of pheochromocytoma in multiple endocrine neoplasia type 2. J Clin Endocrinol Metab, 2005, 90: 3999-4003.
10Brouwers F M, Eisenhofer G, Lenders J W, et al. Emergencies caused by phaeochromocytoma, neuroblastoma or ganglioma. Endocrinol Metab Clin N Am, 2006, 35:699- 724.
3Pacak K, Eisenhofer G, Ahlman H, et al. Pheochromocytoma: Recommandations for clinical practice from the first international symposium [J]. Nat Clin Pract Endocrinol Metab, 2007,3 : 92 - 102.
4Yuan W, Wang W, Cui B, et al. Overexpression of ERBB-2 was more frequently detected in malignant than benign pheochromocytomas by multiplex ligation-dependent probe amplification and immuno-histochemistry [J]. Endocrine Related Cancer, 2008, 15 (1) :343 -350.
